Evidence map›Paper›PMID 35932317›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care.

Juan Carlos Laguna, Tim Cooksley, Shin Ahn, Nikolaos Tsoukalas, Thein Hlaing Oo, Norman Brito-Dellan, Francis Esposito, Carmen Escalante, Carme Font, MASCC Hemostasis Study Group

Abstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Guideline
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Quantitative and qualitative investigation of shunt failure in anFrontiers in bioengineering and biotechnology · 2025
    Article
  11. Article
  12. Review
  13. A Comprehensive Review of Catheter-Related Thrombosis.Journal of clinical medicine · 2024
    Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Juan Carlos LagunaMedical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2357-1186
Tim CooksleyThe Christie Hospital, University of Manchester, Wythenshawe Hospital, Manchester, UK.ORCID http://orcid.org/0000-0001-6114-1956
Shin AhnDepartment of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID http://orcid.org/0000-0001-8642-6552
Nikolaos TsoukalasMedical Oncology Department, General Military Hospital of Athens, 401, Athens, Greece.ORCID http://orcid.org/0000-0002-1455-1503
Thein Hlaing OoSection of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, USA.ORCID http://orcid.org/0000-0002-5201-731X
Norman Brito-DellanDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.ORCID http://orcid.org/0000-0002-5816-9285
Francis EspositoMedical Oncology Department, Upper GI Cancer Unit, Hospital Clinic Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5028-9637
Carmen EscalanteInternal Medicine Department, Anderson Cancer Center, University of Texas, Houston, MD, USA.ORCID http://orcid.org/0000-0003-4287-7823
Carme FontMedical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. carme.fontpuig@gmail.com.ORCID http://orcid.org/0000-0002-3547-7373
MASCC Hemostasis Study Group
Hospital Clínic de Barcelona · ESThe University of Texas MD Anderson Cancer Center · US401 General Military Hospital of Athens · GRUlsan College · KRUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central venous access devices (CVADs) including central venous catheters and peripherally inserted central catheters (PICCs) are essential in the treatment of cancer. Catheter-related thrombosis (CRT) is the most frequent non-infectious complication associated with the use of central lines. The development of CRT may cause to delays in oncologic treatment and increase morbidity leading to potentially life-threatening complications. Several local and systemic risk factors are associated with the development of CRT and should be taken into account to prevent CRT by standardizing appropriate catheter placement and maintenance. The use of primary pharmacological thromboprophylaxis in order to avoid CRT is not routinely recommended, although it can be considered in selected cases. Recommendations for the management of established CRT are based on the extrapolation of anticoagulation for lower limb venous thrombosis. The present review summarizes the current evidence and recommendations for the prevention and management of CRT and identifies areas that require further research.

Indexed as

Catheterization, Central VenousCatheterization, PeripheralCentral Venous CathetersNeoplasmsThrombosisVenous ThromboembolismAnticoagulantsHumansRisk FactorsAnticoagulantsCancer-associated thrombosisCatheter-related thrombosisCentral venous access devicesPeripherally inserted catheter

Identifiers

PMID35932317
OpenAlexW4290038707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.